Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perl

Showing results (171-180 of 3,151) with videos related to

Pageof 316
Sort By:
Autoimmunity|October 17, 2013
Metabolic control of the epigenome in systemic Lupus erythematosusZachary Oaks, Andras Perl
Der Unfallchirurg|October 22, 2016
[The new medical treatment procedure of the German Statutory Accident Insurance: From the perspective of BG hospitals]V Bühren, M Perl
Cutis|May 13, 2014
Field therapy in the treatment of actinic keratosisMarcel Perl, Gary Goldenberg
Der Unfallchirurg|June 7, 2014
[The position of Funktionsoberarzt at German university clinics]M Perl, M Münzberg
Oral Surgery, Oral Medicine, and Oral Pathology|April 1, 1972
Hydatid cyst in the tongueT Perl, B Goldberg
Contributions to Nephrology|September 27, 2021
Can Remote Patient Management Improve Outcomes in Peritoneal Dialysis?Longkai Li, Jeffrey Perl
Ebiomedicine|March 12, 2023
Expanding scope of TEMRA in autoimmunityAndras Perl, Laurence Morel
Current Opinion in Rheumatology|April 4, 2026
Pathogenesis-directed lupus therapeuticsBhavya Poudyal, Andras Perl
Frontiers in Immunology|March 25, 2021
Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8<sup>+</sup> T Cells <i>via</i> STAT6-GATA-3 Axis in Systemic Lupus ErythematosusHiroshi Kato, Andras Perl
Clinical Immunology (Orlando, Fla.)|June 18, 2021
Improvement of renal and non-renal SLE outcome measures on sirolimus therapy - A 21-year follow-up study of 73 patientsParamarajan Piranavan, Andras Perl
Pageof 316

Showing results (171-180 of 3,151) with videos related to

Sort By:
Pageof 316
Autoimmunity|October 17, 2013
Metabolic control of the epigenome in systemic Lupus erythematosusZachary Oaks, Andras Perl
Der Unfallchirurg|October 22, 2016
[The new medical treatment procedure of the German Statutory Accident Insurance: From the perspective of BG hospitals]V Bühren, M Perl
Cutis|May 13, 2014
Field therapy in the treatment of actinic keratosisMarcel Perl, Gary Goldenberg
Der Unfallchirurg|June 7, 2014
[The position of Funktionsoberarzt at German university clinics]M Perl, M Münzberg
Oral Surgery, Oral Medicine, and Oral Pathology|April 1, 1972
Hydatid cyst in the tongueT Perl, B Goldberg
Contributions to Nephrology|September 27, 2021
Can Remote Patient Management Improve Outcomes in Peritoneal Dialysis?Longkai Li, Jeffrey Perl
Ebiomedicine|March 12, 2023
Expanding scope of TEMRA in autoimmunityAndras Perl, Laurence Morel
Current Opinion in Rheumatology|April 4, 2026
Pathogenesis-directed lupus therapeuticsBhavya Poudyal, Andras Perl
Frontiers in Immunology|March 25, 2021
Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8<sup>+</sup> T Cells <i>via</i> STAT6-GATA-3 Axis in Systemic Lupus ErythematosusHiroshi Kato, Andras Perl
Clinical Immunology (Orlando, Fla.)|June 18, 2021
Improvement of renal and non-renal SLE outcome measures on sirolimus therapy - A 21-year follow-up study of 73 patientsParamarajan Piranavan, Andras Perl
Pageof 316